Global Immunoassay Instruments/Analyzers Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Chemiluminescence Immunoassay, Immunofluorescence Analyzers, Radioimmunoassay, Enzyme Linked Immunoassay(EIA), and Consumables & Accessories

By Sample Type;

Serum, Plasma, Whole Blood, Urine, and Tissue Samples

By Product Form;

Standalone Analyzers and Integrated Analyzers

By Device Type;

Outright Sale, and Reagent Rental/Lease

By Application;

Therapeutics Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Disease, and Others

By End-User;

Diagnostic Laboratories, Hospitals, and Blood Bank

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn646464799 Published Date: May, 2025 Updated Date: July, 2025

Immunoassay Instruments/Analyzers Market Overview

Immunoassay Instruments/Analyzers Market (USD Million)

Immunoassay Instruments/Analyzers Market was valued at USD 11,452.75 million in the year 2024. The size of this market is expected to increase to USD 13,989.99 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 2.9%.


Global Immunoassay Instruments/Analyzers Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 2.9 %


Study Period2025 - 2031
Base Year2024
CAGR (%)2.9 %
Market Size (2024)USD 11,452.75 Million
Market Size (2031)USD 13,989.99 Million
Market ConcentrationHigh
Report Pages373
11,452.75
2024
13,989.99
2031

Major Players

  • bioMerieux
  • Abbott Laboratories
  • Roche Diagnostics
  • Diasorin
  • Beckman Coulter
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories
  • Becton Dickinson and Company

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Immunoassay Instruments/Analyzers Market

Fragmented - Highly competitive market without dominant players


The Immunoassay Instruments/Analyzers Market is experiencing robust growth, driven by the increasing demand for precise and efficient diagnostic tools. These instruments are widely used in over 60% of diagnostic laboratories due to their high sensitivity and specificity. This preference stems from their ability to deliver rapid and accurate disease detection, making them essential for modern healthcare settings focused on early diagnosis and personalized treatment.

Advancements in Technology Fueling Market Expansion
Technological innovation continues to shape this market, with nearly 40% of immunoassay analyzers now incorporating advanced features like automation, high-throughput processing, and integrated data analytics. These enhancements significantly boost workflow efficiency, reduce manual errors, and improve patient outcomes, reflecting the industry’s push towards precision diagnostics.

Focus on Early Disease Detection
Early disease detection remains a critical factor driving this market. Immunoassay instruments are extensively used to identify biomarkers for chronic and infectious diseases, accounting for over 50% of all diagnostic tests. This focus on early intervention not only reduces treatment costs but also improves survival rates, highlighting their role in proactive healthcare.

Expanding Use in Clinical Research
Beyond routine diagnostics, these instruments are increasingly utilized in clinical research and drug development. Approximately 30% of immunoassay analyzers are now dedicated to biopharmaceutical testing and vaccine research, underlining their growing significance in cutting-edge medical innovation. This trend aligns with the broader shift towards personalized medicine.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Sample Type
    3. Market Snapshot, By Product Form
    4. Market Snapshot, By Device Type
    5. Market Snapshot, By Application
    6. Market Snapshot, By End-User
    7. Market Snapshot, By Region
  4. Immunoassay Instruments/Analyzers Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Advancements in Automation and High-Throughput Screening
        2. Integration of Immunoassay Systems with Other Diagnostic Modalities
        3. Focus on Personalized Medicine and Biomarker Discovery
        4. Favorable Reimbursement Policies for Immunoassay Testing
      2. Restraints
        1. Complexity of Assay Development and Validation
        2. Reimbursement Constraints and Pricing Pressure
        3. Fragmented Market Landscape
        4. Resistance to Adoption in Certain Healthcare Settings
      3. Opportunities
        1. Development of Novel Biomarkers and Assay Panels
        2. Collaborations and Partnerships with Research Institutions
        3. Customization and Personalization of Assay Platforms
        4. Expansion of Applications in Therapeutic Monitoring
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Immunoassay Instruments/Analyzers Market, By Product, 2021 - 2031 (USD Million)
      1. Chemiluminescence Immunoassay
      2. Immunofluorescence Analyzers
      3. Radioimmunoassay
      4. Enzyme Linked Immunoassay(EIA)
      5. Consumables & Accessories
    2. Immunoassay Instruments/Analyzers Market, By Sample Type, 2021 - 2031 (USD Million)
      1. Serum
      2. Plasma
      3. Whole Blood
      4. Urine
      5. Tissue Samples
    3. Immunoassay Instruments/Analyzers Market, By Product Form, 2021 - 2031 (USD Million)
      1. Standalone Analyzers
      2. Integrated Analyzers.
    4. Immunoassay Instruments/Analyzers Market, By Device Type, 2021 - 2031 (USD Million)
      1. Outright Sale
      2. Reagent Rental/Lease
    5. Immunoassay Instruments/Analyzers Market, By Application, 2021 - 2031 (USD Million)
      1. Therapeutics Drug Monitoring
      2. Oncology
      3. Cardiology
      4. Endocrinology
      5. Infectious Disease Testing
      6. Autoimmune Disease
      7. Others
    6. Immunoassay Instruments/Analyzers Market, By End-User, 2021 - 2031 (USD Million)
      1. Diagnostic Laboratories
      2. Hospitals
      3. Blood Bank
    7. Immunoassay Instruments/Analyzers Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Roche Diagnostics
      2. Abbott Laboratories
      3. Siemens Healthineers
      4. Beckman Coulter (Danaher)
      5. Thermo Fisher Scientific
      6. Bio‑Rad Laboratories
      7. DiaSorin
      8. Ortho Clinical Diagnostics
      9. bioMérieux
      10. Quidel Corporation
      11. Mindray Medical International
      12. Tosoh Bioscience
      13. Luminex Corporation
      14. PerkinElmer
  7. Analyst Views
  8. Future Outlook of the Market